Cargando…

Oral Apolipoprotein A‐I Mimetic D‐4F Lowers HDL‐Inflammatory Index in High‐Risk Patients: A First‐in‐Human Multiple‐Dose, Randomized Controlled Trial

A single dose of the apolipoprotein (apo)A‐I mimetic peptide D‐4F rendered high‐density lipoprotein (HDL) less inflammatory, motivating the first multiple‐dose study. We aimed to assess safety/tolerability, pharmacokinetics, and pharmacodynamics of daily, orally administered D‐4F. High‐risk coronary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dunbar, Richard L., Movva, Rajesh, Bloedon, LeAnne T., Duffy, Danielle, Norris, Robert B., Navab, Mohamad, Fogelman, Alan M., Rader, Daniel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673907/ https://www.ncbi.nlm.nih.gov/pubmed/28795506 http://dx.doi.org/10.1111/cts.12487

Ejemplares similares

Apolipoprotein A-I Mimetic Peptides Prevent Atherosclerosis Development and Reduce Plaque Inflammation in a Murine Model of Diabetes
por: Morgantini, Cecilia, et al.
Publicado: (2010)

HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL
por: Kelesidis, Theodoros, et al.
Publicado: (2011)

HDL as a Biomarker, Potential Therapeutic Target, and Therapy
por: Navab, Mohamad, et al.
Publicado: (2009)

Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity
por: Kelesidis, Theodoros, et al.
Publicado: (2012)

Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis
por: Woo, Jennifer MP, et al.
Publicado: (2010)

Treating the Intestine with Oral ApoA-I Mimetic Tg6F Reduces Tumor Burden in Mouse Models of Metastatic Lung Cancer
por: Chattopadhyay, Arnab, et al.
Publicado: (2018)

Apolipoprotein A-1 mimetic peptide 4F promotes endothelial repairing and compromises reendothelialization impaired by oxidized HDL through SR-B1
por: He, Dan, et al.
Publicado: (2017)

The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
por: Chernick, Dustin, et al.
Publicado: (2020)

Circulating HDL and Non-HDL Associated Apolipoproteins and Breast Cancer Severity
por: Bobin-Dubigeon, Christine, et al.
Publicado: (2022)

Bovine HDL and Dual Domain HDL-Mimetic Peptides Inhibit Tumor Development in Mice
por: Su, Feng, et al.
Publicado: (2020)

Apolipoprotein Mimetic Peptides: A New Approach for the Treatment of Asthma
por: Yao, Xianglan, et al.
Publicado: (2012)

Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases
por: Wolska, Anna, et al.
Publicado: (2021)

Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis
por: Santana, Monique F. M., et al.
Publicado: (2020)

Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties
por: Nguyen, Su Duy, et al.
Publicado: (2016)

Vasculitis, Atherosclerosis, and Altered HDL Composition in Heme-Oxygenase-1-Knockout Mice
por: Ishikawa, Kazunobu, et al.
Publicado: (2012)

Apolipoprotein A-I modulates HDL particle size in the absence of apolipoprotein A-II
por: Melchior, John T., et al.
Publicado: (2021)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113–122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice
por: Rivas-Urbina, Andrea, et al.
Publicado: (2020)

Apolipoprotein A-I mimetic peptide 4F suppresses tumor-associated macrophages and pancreatic cancer progression
por: Peng, Meiyu, et al.
Publicado: (2017)

HDL Mimetics Enhances Mitochondrial Function via Stimulation of PGC1-α
por: Zhang, Hang, et al.
Publicado: (2023)

Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans
por: Brodeur, Mathieu R., et al.
Publicado: (2022)

ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer
por: Cedó, Lídia, et al.
Publicado: (2016)

Apolipoprotein E mimetic peptide protects against diffuse brain injury
por: Zhao, Yaning, et al.
Publicado: (2014)

Apolipoprotein Mimetic Peptides: An Emerging Therapy against Diabetic Inflammation and Dyslipidemia
por: Wolkowicz, Paul, et al.
Publicado: (2021)

HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option?
por: Karalis, I., et al.
Publicado: (2018)

Stability Characterization of the Novel Anti-Cancer HM-10/10 HDL-Mimetic Peptide
por: Dempsey, Michael P., et al.
Publicado: (2023)

Effect of fasting and feeding on apolipoprotein A-I kinetics in preβ(1)-HDL, α-HDL, and triglyceride-rich lipoproteins
por: Chétiveaux, Maud, et al.
Publicado: (2020)

Anti-tumorigenic and Platinum-Sensitizing Effects of Apolipoprotein A1 and Apolipoprotein A1 Mimetic Peptides in Ovarian Cancer
por: Marinho, Aline T., et al.
Publicado: (2019)

The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial Infarction
por: Hamid, Tariq, et al.
Publicado: (2020)

Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis
por: Getz, Godfrey S, et al.
Publicado: (2011)

Apolipoprotein E mimetic peptide, CN‐105, improves outcomes in ischemic stroke
por: Tu, Tian Ming, et al.
Publicado: (2017)

Complex association of apolipoprotein E–containing HDL with coronary artery disease burden in cardiovascular disease
por: Sorokin, Alexander V., et al.
Publicado: (2022)

The Apolipoprotein-AI Mimetic Peptide L4F at a Modest Dose Does Not Attenuate Weight Gain, Inflammation, or Atherosclerosis in LDLR-Null Mice
por: Averill, Michelle M., et al.
Publicado: (2014)

Assessing HDL Metabolism in Subjects with Elevated Levels of HDL Cholesterol and Coronary Artery Disease
por: Hancock-Cerutti, William, et al.
Publicado: (2021)

Lipid-bound apolipoproteins in tyrosyl radical-oxidized HDL stabilize ABCA1 like lipid-free apolipoprotein A-I
por: Hossain, Mohammad A, et al.
Publicado: (2012)

Transport of Apolipoprotein B-Containing Lipoproteins through Endothelial Cells Is Associated with Apolipoprotein E-Carrying HDL-Like Particle Formation
por: Yang, Hong, et al.
Publicado: (2018)

Structural properties of apolipoprotein A-I mimetic peptides that promote ABCA1-dependent cholesterol efflux
por: Islam, Rafique M., et al.
Publicado: (2018)

The apolipoprotein A‐I mimetic peptide, D‐4F, restrains neointimal formation through heme oxygenase‐1 up‐regulation
por: Liu, Donghui, et al.
Publicado: (2017)

Apolipoprotein A-I Mimetic Peptide L-4F Suppresses Granulocytic-Myeloid-Derived Suppressor Cells in Mouse Pancreatic Cancer
por: Peng, Meiyu, et al.
Publicado: (2020)

Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulations
por: Gomaraschi, Monica, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vt6s35joc0nlhfpncsf01e5593